Match!

The value of improving the productivity of the drug development process: faster times and better decisions.

Published on Jan 1, 2002in PharmacoEconomics3.71
· DOI :10.2165/00019053-200220003-00001
Joseph A. DiMasi26
Estimated H-index: 26
(Tufts University)
Abstract
Objectives: This study examines the financial benefits that can accrue to drug developers from improvements in the drug development process. The effect on drug development costs from faster development, earlier decisions on project failures, and higher approval success rates are quantified.
  • References (13)
  • Citations (173)
References13
Newest
#1Joseph A. DiMasi (Tufts Center for the Study of Drug Development)H-Index: 26
#2Ronald W. Hansen (UR: University of Rochester)H-Index: 7
Last.Henry G. Grabowski (Duke University)H-Index: 39
view all 3 authors...
3,045 CitationsSource
2 CitationsSource
#1Karen J. WatkinsH-Index: 1
12 CitationsSource
#1Henry G. Grabowski (Duke University)H-Index: 39
#2John M Vernon (Duke University)H-Index: 17
Last.Joseph A. DiMasi (Tufts University)H-Index: 26
view all 3 authors...
221 CitationsSource
#1Joseph A. DiMasi (Tufts Center for the Study of Drug Development)H-Index: 26
183 CitationsSource
#1Joseph A. DiMasi (Tufts Center for the Study of Drug Development)H-Index: 26
359 CitationsSource
#1Joseph A. DiMasi (Tufts University)H-Index: 26
#2Erol Caglarcan (Johnson & Johnson)H-Index: 1
Last.Maria Wood-Armany (Tufts University)H-Index: 1
view all 3 authors...
53 CitationsSource
#1Christopher-Paul Milne (Tufts Center for the Study of Drug Development)H-Index: 11
#2Elaine Bergman (Tufts Center for the Study of Drug Development)H-Index: 1
11 CitationsSource
#1Joseph A. DiMasi (Tufts Center for the Study of Drug Development)H-Index: 26
58 CitationsSource
#1Kenneth I. Kaitin (Tufts Center for the Study of Drug Development)H-Index: 23
#2Joseph A. DiMasi (Tufts Center for the Study of Drug Development)H-Index: 26
36 CitationsSource
Cited By173
Newest
#1Joanne Neale ('KCL': King's College London)H-Index: 27
#2Charlotte N. E. Tompkins ('KCL': King's College London)H-Index: 12
Last.John Strang ('KCL': King's College London)H-Index: 62
view all 3 authors...
1 CitationsSource
#1Nandini Dhiman (Swinburne University of Technology)H-Index: 1
#2Peter Kingshott (Swinburne University of Technology)H-Index: 40
Last.Subha Narayan Rath (IITH: Indian Institute of Technology, Hyderabad)H-Index: 15
view all 5 authors...
2 CitationsSource
#1Xuhua Han (CSU: Central South University)
#2Fang Li (CSU: Central South University)
Last.Zeneng Cheng (CSU: Central South University)H-Index: 11
view all 6 authors...
Source
#1S. Lakshmana Prabu (Anna University)H-Index: 4
1 CitationsSource
#1Thomas Walter (RWTH Aachen University)H-Index: 2
#2Christoph Ihl (RWTH Aachen University)H-Index: 7
Last.Malte Brettel (RWTH Aachen University)H-Index: 29
view all 4 authors...
6 CitationsSource
#1Qi Chen (Imperial College London)H-Index: 1
#2Remigijus Paulavičius (Imperial College London)H-Index: 9
Last.Salvador García-Muñoz (Eli Lilly and Company)H-Index: 16
view all 4 authors...
2 CitationsSource
Source
#1Hsin-Ning Su (NCTU: National Chiao Tung University)H-Index: 11
#2Yi-Siang Lin (NCHU: National Chung Hsing University)
Source
#1Joanne Neale ('KCL': King's College London)H-Index: 27
#2Charlotte N. E. Tompkins ('KCL': King's College London)H-Index: 12
Last.John Strang ('KCL': King's College London)H-Index: 62
view all 4 authors...
9 CitationsSource
#1Joseph A. DiMasi (Tufts Center for the Study of Drug Development)H-Index: 26
#2Zachary C. Smith (Tufts Center for the Study of Drug Development)H-Index: 6
Last.Kenneth A. Getz (Tufts Center for the Study of Drug Development)H-Index: 15
view all 3 authors...
1 CitationsSource
View next paperThe price of innovation: new estimates of drug development costs